Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Confirmation of reduction of capital

June 10, 2020
Download  full announcement Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that it has yesterday

Proposed dual-listing on Nasdaq

May 18, 2020
Download  full announcement Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that it has confidentially

Renalytix AI Announces Proposed Dual-listing on Nasdaq

May 18, 2020
NEW YORK, May 18, 2020 /PRNewswire/ --  Renalytix AI plc  (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that it has
Displaying 31 - 40 of 128